Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold J Burstein

Showing results (11-20 of 250) with videos related to

Pageof 25
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2012
A "shot heard 'round the world" on cancer drug costs?Harold J Burstein
The New England Journal of Medicine|December 28, 2020
Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast CancerHarold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2012
Simplifying guidelines: we only need one adjuvant chemotherapy regimen for breast cancerHarold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|October 26, 2010
Board recertificationHarold J Burstein
Breast (Edinburgh, Scotland)|August 28, 2007
Cognitive side-effects of adjuvant treatmentsHarold J Burstein
Breast (Edinburgh, Scotland)|December 20, 2021
Unmet challenges in systemic therapy for early stage breast cancerHarold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2009
Do clinical trials belong in clinical guidelines?Harold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|October 23, 2008
Oncology teamworkHarold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|July 29, 2009
Quality measures, clinical practice, NCCN, and McAllen, TexasHarold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2011
Avastin for breast cancer, 2005-2011: requiescat in pacem?Harold J Burstein
Pageof 25

Showing results (11-20 of 250) with videos related to

Sort By:
Pageof 25
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2012
A "shot heard 'round the world" on cancer drug costs?Harold J Burstein
The New England Journal of Medicine|December 28, 2020
Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast CancerHarold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2012
Simplifying guidelines: we only need one adjuvant chemotherapy regimen for breast cancerHarold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|October 26, 2010
Board recertificationHarold J Burstein
Breast (Edinburgh, Scotland)|August 28, 2007
Cognitive side-effects of adjuvant treatmentsHarold J Burstein
Breast (Edinburgh, Scotland)|December 20, 2021
Unmet challenges in systemic therapy for early stage breast cancerHarold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2009
Do clinical trials belong in clinical guidelines?Harold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|October 23, 2008
Oncology teamworkHarold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|July 29, 2009
Quality measures, clinical practice, NCCN, and McAllen, TexasHarold J Burstein
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2011
Avastin for breast cancer, 2005-2011: requiescat in pacem?Harold J Burstein
Pageof 25